INTERNATIONAL PATENT: MEVIXAGA (BEIJING) MEDICAL TECHNOLOGY CO., LTD, 明兰世迦（北京）医疗科技有限公司 FILES APPLICATION FOR "HIGH-GRADE CERVICAL CELL LESION RISK PREDICTION METHOD AND SYSTEM"

GENEVA, June 2 -- MEVIXAGA (BEIJING) MEDICAL TECHNOLOGY CO., LTD (303-156, 3rd Floor, Building 4, No. 9 Medical Road, Life Science ParkChangping District, Beijing 102206), 明兰世迦（北京）医疗科技有限公司 (中国北京市昌平区生命科学园医科路9号院4号楼三层303-156) filed a patent application (PCT/CN2024/113554) for "HIGH-GRADE CERVICAL CELL LESION RISK PREDICTION METHOD AND SYSTEM" on Aug 21, 2024. With publication no. WO/2025/107761, the details related to the patent application was published on May 30, 2025.

Notably, t...